Idiopathic pulmonary fibrosis

Cancer Incidence in Five Continents

Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,378

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196

Fleischner Society: Glossary of Terms for Thoracic Imaging

Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Rémy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,189

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975

Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement

(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,651

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline

Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916

Grape Phytochemicals and Vitamin D in the Alleviation of Lung Disorders

Santa, K. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220407002936 · Cited by 12

Tryptanthrin alleviate lung fibrosis via suppression of MAPK/NF-κB and TGF-β1/SMAD signaling pathways in vitro and in vivo

Niu, M., Wang, Y., Deng, X.-M., Wu, X., Hua, Z.-Y., & Lü, T. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117285 · Cited by 11

Revealing a new target: Celastrol alleviates pulmonary fibrosis by inhibiting PCAF

Wang, L., Lin, F., Liu, J., Jia, Z., Zhu, M., Liu, Y., Li, Y., & Yang, L. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108722 · Cited by 10

Identification of the Molecular Subgroups in Idiopathic Pulmonary Fibrosis by Gene Expression Profiles

Zhang, N., Guo, Y., Wu, C., Jiang, B., & Wang, Y. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/7922594 · Cited by 11

Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury

Hashemian, S. M. R., Farhadi, T., Varahram, M., & Velayati, A. A. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2153116 · Cited by 11

Relaxin-Loaded Inhaled Porous Microspheres Inhibit Idiopathic Pulmonary Fibrosis and Improve Pulmonary Function Post-Bleomycin Challenges

Qiu, S., Fu, X., Shi, Y., Zang, H., Zhao, Y., Qin, Z., Lin, G., & Zhao, X. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00111 · Cited by 12

Combining single-cell RNA sequencing data and transcriptomic data to unravel potential mechanisms and signature genes of the progression of idiopathic pulmonary fibrosis to lung adenocarcinoma and predict therapeutic agents

Zhou, X., Tan, F., Zhang, S., & Zhang, T. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01274-y · Cited by 11

S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis

Lee, J.-U., Kim, M. K., Kim, M., Lee, S. J., Park, S.-L., Chang, H. S., Park, J.-S., & Park, C. S. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e13 · Cited by 11

Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway

Yin, J.-Z., Li, Z.-Q., Zhang, X., Wan, Z.-J., Qin, H.-R., Yao, L.-H., Li, B.-L., 高福, & Yang, Y.-Y. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176293 · Cited by 11

Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin

Cai, L., Wang, J., Xue, Y., Yu, S., Wang, C., Zhang, L., Zhang, X., Cheng, L., Ruan, W., Dong, F., et al. (2024) · Pediatric Research · doi:10.1038/s41390-024-03024-7 · Cited by 11

Circular RNAs and their roles in idiopathic pulmonary fibrosis

Surendran, A. M., Huang, C., & Liu, L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02716-2 · Cited by 13

Demethyleneberberine Alleviates Pulmonary Fibrosis through Disruption of USP11 Deubiquitinating GREM1

Ge, C., Huang, M., Han, Y., Shou, C., Li, D., & Zhang, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17030279 · Cited by 11

Drugs targeting CTGF in the treatment of pulmonary fibrosis

Qiu, Y., Que, Y., Ding, Z., Zhang, S., Wei, R., Xia, J., & Lin, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18448 · Cited by 10

The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?

Ghanem, M., Archer, G., Crestani, B., & Mailleux, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108669 · Cited by 12

Physalis Calyx seu Fructus inhibited pulmonary fibrosis through regulating Wnt/β-catenin signaling pathway

Wang, T., Xu, L., Li, P., Zhang, C.-H., Zhang, C.-H., Wang, X., Xiang, L., Xu, Z.-P., & Shen, T. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155797 · Cited by 12

Early diagnosis and staging of paraquat-induced pulmonary fibrosis using [18F]F-FAPI-42 PET/CT imaging

Zhang, D., Shi, Y., Kong, J., Chen, N., Li, G., Wang, M.-F., Zhang, G., & Zhai, C. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01118-1 · Cited by 11

Impaired GPX4 activity elicits ferroptosis in alveolar type II cells promoting PHMG-induced pulmonary fibrosis development

Zhang, W., Sun, Z., Cheng, W., Li, X., Zhang, J., Li, Y., Tan, H., Ji, X., Zhang, L., & Tang, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116680 · Cited by 11

Chronic stress causes ovarian fibrosis to impair female fertility in mice

Ma, J., Wang, L., Yang, D., Luo, J., Gao, J., Wang, J., Guo, H., Li, J., Wang, F., Wu, J., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111334 · Cited by 11

MEOX1 triggers myofibroblast apoptosis resistance, contributing to pulmonary fibrosis in mice

Jin, L., Bao, B., Huang, X., Tao, J., Duan, J., Zhong, W., Zhang, C., Liu, Y., Chen, H., Yang, N., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31442 · Cited by 11

Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis

Li, K., Liu, X., Lu, R., Zhao, P., Tian, Y., & Li, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117451 · Cited by 11

Ultrasonic Microfluidic Method Used for siHSP47 Loaded in Human Embryonic Kidney Cell-Derived Exosomes for Inhibiting TGF-β1 Induced Fibroblast Differentiation and Migration

Yuan, R., Mu, Z., Zhang, H., Guo, J., Tian, Y., Xin, Q., Zhu, X., Dong, Z., Wang, H., & Shi, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010382 · Cited by 12

The dual missions of FoxO3a in inflammatory diseases: Regulation of antioxidant enzymes and involvement in programmed cell death

Ma, X., Lin, Y., Zhang, L., Huang, Z., Zhang, Y., Fu, X., & Li, P. A. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114369 · Cited by 12

The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases

Zhang, W., Wang, R., Guo, R., Yi, Z., Wang, Y., Wang, H., Li, Y., Li, X., & Song, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1538601 · Cited by 11

The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer

Zhong, B., Du, J., Liu, F., & Sun, S. (2025) · MedComm · doi:10.1002/mco2.70128 · Cited by 10

Ferroptosis: the potential key roles in idiopathic pulmonary fibrosis

Song, L., Fusheng, G., & Man, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02623-2 · Cited by 11

Assessment and Management of Occupational Hypersensitivity Pneumonitis

Ojanguren, Í., Ferraro, V., Morisset, J., Muñoz, X., Fink, J. N., & Cruz, M. J. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.002 · Cited by 11

Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis

Okano, T., Kobayashi, T., Yasuma, T., D’Alessandro‐Gabazza, C. N., Toda, M., Fujimoto, H., Nakahara, H., Okano, Y., Takeshita, A., Nishihama, K., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.593620 · Cited by 11

FibROAD: a manually curated resource for multi-omics level evidence integration of fibrosis research

Sun, Y., Hu, Y., Zhang, Y., Wei, S., Yang, B., Xu, Y., Rong, Z.-L., Yang, B., & Yang, B. (2022) · Database · doi:10.1093/database/baac015 · Cited by 11

An estrogen-sensitive fibroblast population drives abdominal muscle fibrosis in an inguinal hernia mouse model

Potluri, T., Taylor, M. J., Stulberg, J. J., Lieber, R. L., Zhao, H., & Bulun, S. E. (2022) · JCI Insight · doi:10.1172/jci.insight.152011 · Cited by 12

Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D

Cox, I. A., Campbell, J. A., de Graaff, B., Otáhal, P., Corte, T. J., Moodley, Y. P., Hopkins, P. M.-A., Macansh, S., Walters, E. H., & Palmer, A. J. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03205-z · Cited by 13

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study

Cox, I. A., de Graaff, B., Ahmed, H., Campbell, J. A., Otáhal, P., Corte, T. J., Moodley, Y. P., Goh, N. S. L., Hopkins, P. M.-A., Macansh, S., et al. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01538-7 · Cited by 11

FOXO4-D-Retro-Inverso targets extracellular matrix production in fibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice

Liu, Y., Hou, Q., Wang, R., Liu, Y., & Cheng, Z. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02452-2 · Cited by 11

Magnolol alleviates pulmonary fibrosis inchronic obstructive pulmonary disease by targeting transient receptor potential vanilloid 4‐ankyrin repeat domain

Niu, L., Lu, Y., Zu, X., Yang, W., Shen, F., Xu, Y., Jiang, M., Xie, Y., Li, S., Gao, J., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7907 · Cited by 11

Integrative analysis reveals the recurrent genetic etiologies in idiopathic pulmonary fibrosis

Guo, S., Dong, Y., Wang, C., Jiang, Y., Xiang, R., Fan, L., Luo, H., & Liu, L. (2023) · QJM · doi:10.1093/qjmed/hcad206 · Cited by 12

Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren’s syndrome-related interstitial lung disease

Shi, L., Fu, Q., Chen, N., Liu, R., & Zheng, Y. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00623-6 · Cited by 11

Identification and functional characterization of a novel surfactant protein A2 mutation (p.N207Y) in a Chinese family with idiopathic pulmonary fibrosis

Liu, L., Qin, J., Guo, T., Chen, P., Ouyang, R., Peng, H., & Luo, H. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1393 · Cited by 13

The Combined Model of CX3CR1-Related Immune Infiltration Genes to Evaluate the Prognosis of Idiopathic Pulmonary Fibrosis

Cai, H., Chen, S., Li, X., Liu, H., Zhang, Y., & Zhuang, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.837188 · Cited by 11

Prevention of Bleomycin‐Induced Pulmonary Inflammation and Fibrosis in Mice by Bilobalide

Zhang, X., Zhang, W., Chen, X., & Cai, Y. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/1973163 · Cited by 11

The Role of Immunity and Inflammation in IPF Pathogenesis

Butler, M. W., & Keane, M. P. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_6 · Cited by 12

P27 Promotes TGF-β-Mediated Pulmonary Fibrosis via Interacting with MTORC2

Dai, Y.-H., Li, X., Dong, D.-P., Gu, H., Kong, C.-Y., & Xu, Z. (2019) · Canadian Respiratory Journal · doi:10.1155/2019/7157861 · Cited by 11

Idiopathic pulmonary fibrosis and occupational risk factors

Ranzieri, S., Magrini, E. I., Mozzoni, P., Andreoli, R., Pelà, G. M., Bertorelli, G., & Corradi, M. (2019) · La Medicina del Lavoro · doi:10.23749/mdl.v110i6.8970 · Cited by 12

Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey

Walsh, S. L. F., & Richeldi, L. (2019) · European Respiratory Journal · doi:10.1183/13993003.00906-2019 · Cited by 11

Triggering AHR resolves TGF-β1 induced fibroblast activation and promotes AT1 cell regeneration in alveolar organoids

Hagan, A. S., Williams, S., Mathison, C. J. N., Yan, S., Nguyen, B., Federe, G. C., Kuzu, G., Siefert, J. C., Hampton, J., Chichkov, V., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08446-5 · Cited by 12

Integrated multicomponent analysis based on UHPLC‐Q‐Exactive Orbitrap‐MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis

Zhang, B., Gao, D., Xu, G., Zhu, W., Liu, J., Sun, R., Wang, L., Zhang, C., Ding, Q., & Shi, Y. (2022) · Phytochemical Analysis · doi:10.1002/pca.3120 · Cited by 10

Alamandine: A promising treatment for fibrosis

Fernandes, R. S., Netto, M. R. T., Carvalho, F. B., & Rigatto, K. (2022) · Peptides · doi:10.1016/j.peptides.2022.170848 · Cited by 11

Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis

Ren, J., Ding, Y., Zhao, J., & Sun, Y. (2022) · Rheumatology International · doi:10.1007/s00296-022-05219-9 · Cited by 10

NOX4–TIM23 interaction regulates NOX4 mitochondrial import and metabolic reprogramming

Pandey, J., Larson‐Casey, J. L., Patil, M. H., Joshi, R., Jiang, C., Zhou, Y., He, C., & Carter, A. B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104695 · Cited by 10

Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death

Carignon, S., Rodrigues, D. D. M., Gosset, D., Culerier, E., Huot-Marchand, S., Savigny, F., Kaya, E., Quesniaux, V. F. J., Gombault, A., Couillin, I., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1261483 · Cited by 10

Betanin protects against bleomycin-induced pulmonary fibrosis by regulating the NLRP3/IL-1β/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition

Elrazik, N. A. A., & Helmy, S. A. (2023) · Food & Function · doi:10.1039/d3fo03464j · Cited by 11

The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway

Pan, J., Li, Y., Wu, X., Pan, X., Liu, C., Zhang, H., Wang, L., Jiang, X., Wang, J., Zang, N., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117507 · Cited by 10

Tanshinone IIA alleviates bleomycin-induced pulmonary fibrosis by inhibiting Zbtb16

Zhang, H., Qiu, J., Zhao, Q., Zhang, Y., Zheng, H., Dou, Z., & Yan, Y. (2024) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2024.102285 · Cited by 10

Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip

Vo, Q., & Benam, K. H. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106709 · Cited by 10

Cevanine-type alkaloids from the bulbs of Fritillaria unibracteata var. wabuensis and their antifibrotic activities in vitro

Fu, L., Tian, W., Bao, M.-Y., Liu, Z., Ren, W.-J., Liu, J., Zhang, W., Zhang, Z., Gao, J., Bai, L., et al. (2024) · Phytochemistry · doi:10.1016/j.phytochem.2024.114018 · Cited by 10

Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development

Guo, J., & Liyang, Y. A. N. G. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2023-100 · Cited by 10

Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review

Enomoto, N. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.03.006 · Cited by 12

Enhanced Detection of Early Pulmonary Fibrosis Disease Using 68Ga-FAPI-LM3 PET

Chen, J., Luo, D., Dai, Y., Zhou, Y., Pang, Y., Wu, H., Sun, L., Su, G., Lin, Q., Zhao, L., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00405 · Cited by 10

Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1A

Zhao, T., Zhou, Z., Wan, H., Feng, T., Hu, X.-H., Li, X., Zhao, S., Li, H., Hou, J., Li, W., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01368-8 · Cited by 11

ESR Essentials: imaging in fibrotic lung diseases—practice recommendations by the European Society of Thoracic Imaging

Larici, A. R., Biederer, J., Cicchetti, G., Franquet, T., Screaton, N., Rémy‐Jardin, M., Parkar, A. P., Prosch, H., Schaefer‐Prokop, C. M., Frauenfelder, T., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11054-2 · Cited by 11

Tanshinone IIA Loaded Inhaled Polymer Nanoparticles Alleviate Established Pulmonary Fibrosis

Chen, W., Gao, Y., Liu, Y., Luo, Y., Xue, X., Xiao, C., & Wei, K. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00532 · Cited by 10

The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation

Kortekaas, R. K., Geillinger‐Kästle, K. E., Fuentes‐Mateos, R., Schoenleber, A., van der Koog, L., Elferink, R. A. B., Al‐Alyan, N., Burgess, J. K., & Gosens, R. (2024) · The FASEB Journal · doi:10.1096/fj.202302405rr · Cited by 11

Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis

Hong, J., Pham, T. X., Lee, J., Raslan, A., Nicolas, K., Sharov, A. A., Meridew, J. A., Urrutia, R. A., Lomberk, G. A., Huang, S. K., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0255oc · Cited by 10

Air pollution, metabolic signatures, and the risk of idiopathic pulmonary fibrosis

Wang, Y., Tian, F., Qian, Z. M., Feng, J., Wang, X., McMillin, S. E., Howard, S. W., & Lin, H. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.178409 · Cited by 10

Involvement of lncRNA MIR205HG in idiopathic pulmonary fibrosis and IL-33 regulation via Alu elements

Takashima, T., Zeng, C., Murakami, E., Fujiwara, N., Kohara, M., Nagata, H., Feng, Z., Sugai, A., Harada, Y., Ichijo, R., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187172 · Cited by 11

Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation

Deng, Z., Chen, J., Yang, R., Zhan, Y., Chen, S., Zhang, J., Fu, H., Gu, Y., Huang, Q., Wu, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202415007 · Cited by 11

Advances in mRNA-LNP lung-targeted delivery strategies

Liu, X., Ji, S., Cai, Y., Yang, F., You, J., & Luo, L. (2025) · Microstructures · doi:10.20517/microstructures.2024.172 · Cited by 10

Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis

Santoleri, F., Auriemma, L., Spacone, A., Marinari, S., Esposito, F., Vita, F. D., Petragnani, G., Fabio, C. D., Fabio, L. D., & Costantini, A. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211008625 · Cited by 14

BSDE: barycenter single-cell differential expression for case–control studies

Zhang, M., & Guo, F. R. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac171 · Cited by 10

Acute oxygen desaturation characterizes pulmonary aspiration in patients with gastroesophageal reflux disease and laryngopharyngeal reflux

Weerasinghe, D. P., Burton, L., Chicco, P., Pearson, M., Mackey, D. J., & Falk, G. L. (2022) · Physiological Reports · doi:10.14814/phy2.15367 · Cited by 10

Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury

van Gijsel‐Bonnello, M., Darling, N. J., Tanaka, T., Carmine, S. D., Marchesi, F., Thomson, S. M., Clark, K., Kurowska‐Stolarska, M., McSorley, H. J., Cohen, P., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102644 · Cited by 11

TGF-β changes cyto/mito-ribosome balance to target respiratory chain complex V biogenesis in pulmonary fibrosis therapy

Zhang, N., Zhao, Z., Zhao, Y., Yang, L., Xue, Y., Feng, Y. W., Luo, J., Chen, R., Wei, W., & Qin, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01370-2 · Cited by 10

The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study

Zheng, Q., Otáhal, P., Cox, I. A., de Graaff, B., Campbell, J. A., Ahmad, H., Walters, E. H., & Palmer, A. J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1157706 · Cited by 10

Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer

Li, S., Li, Y., Liu, Y., Wu, Y., Wang, Q., Jin, L., & Zhang, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108642 · Cited by 11

Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study

Huang, D., Gong, L., Wu, Z., Shi, Y., & Liang, Z. (2023) · Lung · doi:10.1007/s00408-023-00640-8 · Cited by 11

Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning

Luo, H., Yan, J., & Zhou, X. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02699-8 · Cited by 12

Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis

Zhu, X., Ji, J., & Han, X. (2023) · Journal of Molecular Histology · doi:10.1007/s10735-023-10169-y · Cited by 10

YuPingFeng (YPF) upregulates caveolin-1 (CAV1) to alleviate pulmonary fibrosis through the TGF-β1/Smad2 pathway

Chen, X., Wei, M., Li, G., Sun, Q.-L., Fan, J.-Q., Li, J., Yun, C.-M., Liu, D., Shi, H., & Qu, Y.-Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117357 · Cited by 11

Exploring therapeutic targets for molecular therapy of idiopathic pulmonary fibrosis

Li, Y., Jiang, C., Zhu, W., Lu, S., Yu, H., & Meng, L. (2024) · Science Progress · doi:10.1177/00368504241247402 · Cited by 10

The Roles of MicroRNAs and Extracellular Vesicles in the Pathogeneses of Idiopathic Pulmonary Fibrosis and Acute Respiratory Distress Syndrome

Yamada, M. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.251.313 · Cited by 10

Identification of key modules and hub genes associated with lung function in idiopathic pulmonary fibrosis

Xia, Y., Lei, C., Yang, D., & Luo, H. (2020) · PeerJ · doi:10.7717/peerj.9848 · Cited by 11

A long‐acting isomer of Ac‐SDKP attenuates pulmonary fibrosis through SRPK1 ‐mediated PI3K / AKT and Smad2 pathway inhibition

Qiu, Y., Wang, Z., Zhang, X., Huang, P., Zhang, W., Zhang, K., Wang, S., He, L., Guo, Y., An, X., et al. (2020) · IUBMB Life · doi:10.1002/iub.2389 · Cited by 10

A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis

Wu, Q., Xu, Y., Zhang, K., Jiang, S., Zhou, Y., & Zhao, Y. (2020) · BioMed Research International · doi:10.1155/2020/8848919 · Cited by 11

Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial–Mesenchymal Transition

Zhou, Y., Hill, C. N., Yao, L., Li, J., Hancock, D. C., Downward, J., Jones, M. G., Davies, D. E., Ewing, R. M., Skipp, P. J. S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.595712 · Cited by 10

CREB-dependent LPA-induced signaling initiates a pro-fibrotic feedback loop between small airway basal cells and fibroblasts

Nathan, S., Zhang, H., Andreoli, M., Leopold, P. L., & Crystal, R. G. (2021) · Respiratory Research · doi:10.1186/s12931-021-01677-0 · Cited by 10

Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway

Ruan, H., Gao, S., Li, S., Luan, J., Jiang, Q., Li, X., Yin, H.-J., Zhou, H., & Yang, C. (2021) · Molecules · doi:10.3390/molecules26092820 · Cited by 10

Hispidin attenuates bleomycin-induced idiopathic pulmonary fibrosis via an anti-oxidative effect in A549 cells

Ren, C., Jin, X., XIE, D.-P., Guo, X., Yu, L., Cui, Y., Kwon, T., & Sun, H. (2021) · Applied Biological Chemistry · doi:10.1186/s13765-021-00646-x · Cited by 10

Modeling lung diseases using reversibly immortalized mouse pulmonary alveolar type 2 cells (imPAC2)

Zhang, L., Luo, W., Liu, J., Xu, M., Peng, Q., Zou, W., You, J., Shu, Y., Zhao, P., Wagstaff, W., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00894-4 · Cited by 10

(−)‑Epigallocatechin‑3‑O‑gallate upregulates the expression levels of miR‑6757‑3p, a suppressor of fibrosis‑related gene expression, in extracellular vesicles derived from human umbilical vein endothelial cells

Murata, M., Marugame, Y., Morozumi, M., Murata, K., Kumazoe, M., Fujimura, Y., & Tachibana, H. (2023) · Biomedical Reports · doi:10.3892/br.2023.1601 · Cited by 11

Idiopathic pulmonary fibrosis

Vega‐Olivo, M., & Criner, G. J. (2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000531121.07294.36 · Cited by 10

Diverse cellular players orchestrate regeneration after wounding

Williams, K. L., & Garza, L. A. (2020) · Experimental Dermatology · doi:10.1111/exd.14248 · Cited by 10

Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary Fibrosis

Aussedat, P. H., Chebib, N., Ahmad, K., Glérant, J., Drevet, G., Grima, R., Maury, J., Nasser, M., Thivolet-Béjui, F., Traclet, J., et al. (2020) · Respiration · doi:10.1159/000509557 · Cited by 10

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone

He, X., Zhong, Z., Wang, Q., Jia, Z., Lü, J., Chen, J., & Liu, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1127219 · Cited by 9

Sirtuin 6 ameliorates bleomycin‐induced pulmonary fibrosis via activation of lipid catabolism

He, J., Yu, C., Shen, Y., Huang, J., Zhou, Y., Gu, J., Cao, Y., & Zheng, Q. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31027 · Cited by 9

Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome

Tseng, Y., Chen, I., Li, W., & Hsu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310876 · Cited by 10

Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway

Zhao, K., Nie, H., Tang, Z., Chen, G., & Huang, J. (2023) · Aging · doi:10.18632/aging.205092 · Cited by 9

FGF18

Goldschagg, M. G. E., & Hockman, D. (2023) · Differentiation · doi:10.1016/j.diff.2023.10.003 · Cited by 9

Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies

Singh, P., Guin, D., PATTNAIK, B. R., & Kukreti, R. (2023) · Gene · doi:10.1016/j.gene.2023.147993 · Cited by 11

CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling

Naoi, H., Suzuki, Y., Miyagi, A., Horiguchi, R., Aono, Y., Inoue, Y., Yasui, H., Hozumi, H., Karayama, M., Furuhashi, K., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300285 · Cited by 9

Unraveling the Molecular Regulation of Ferroptosis in Respiratory Diseases

Zhu, L., Zhou, J., Yu, C., Gu, L., Wang, Q., Xu, H., Zhu, Y., Guo, M., Hu, M., Peng, W., et al. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s457092 · Cited by 9

Discovery of novel pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione (PBD) derivatives as selective HDAC6 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo

Li, Y., Yang, H., Zhao, X., Zhao, X., Quan, J., Wang, L., Ma, E., & Ma, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116608 · Cited by 9

Evaluating a Specific Dual ROCK Inhibitor against Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats

Liu, L., Song, W., Zeng, J., & Peng, Z. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00149 · Cited by 8

Pronostic et exacerbations aiguës de la fibrose pulmonaire idiopathique

Uzunhan, Y. (2010) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(10)70127-0

Idiopathic Pulmonary Fibrosis: An Overview

May, J., & Jenkins, G. R. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm50844 · Cited by 1

New Aspects of Idiopathic Pulmonary Fibrosis

Molina‐Molina, M., Vicens, V., & Estany, S. (2010) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e3181e4bb22 · Cited by 1

Re-dimensioning the treatment paradigm in idiopathic pulmonary fibrosis

Richeldi, L. (2018) · Monografías de Archivos de Bronconeumología

Idiopathic pulmonary fibrosis and progressive fibrotic interstitial lung disease

Evans, P., Rowlands, E., & Hope‐Gill, B. (2023) · Medicine · doi:10.1016/j.mpmed.2023.09.001 · Cited by 3